These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 15347695)
1. The helmet sign: Physiologic radioactive accumulation after 131I therapy--a case report. Ash L; Bybel B; Neumann D; Beebe W J Nucl Med Technol; 2004 Sep; 32(3):164-5. PubMed ID: 15347695 [TBL] [Abstract][Full Text] [Related]
2. False-positive "necklace sign" on whole-body thyroid cancer survey--a case report. Beaulieu S; Djang D; Minoshima S J Nucl Med Technol; 2005 Mar; 33(1):42-3. PubMed ID: 15731020 [TBL] [Abstract][Full Text] [Related]
3. Contamination of a bracelet following iodine-131 therapy: a case report. Bybel B; Beebe W; Kim BY; Faiman C J Nucl Med Technol; 2000 Dec; 28(4):257-8. PubMed ID: 11142327 [TBL] [Abstract][Full Text] [Related]
4. 123I isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer: comparison with post 131I therapy whole body scanning. Alzahrani AS; Bakheet S; Al Mandil M; Al-Hajjaj A; Almahfouz A; Al Haj A J Clin Endocrinol Metab; 2001 Nov; 86(11):5294-300. PubMed ID: 11701695 [TBL] [Abstract][Full Text] [Related]
5. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer. Zakavi SR; Kakhki VD Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349 [No Abstract] [Full Text] [Related]
6. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer. de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550 [TBL] [Abstract][Full Text] [Related]
7. [Pericardial effusion as a possible cause of false positives in I-131 radionuclide scans]. López Aznar D; García Sanchís L; Rivas Sánchez A; Alonso Monfort J; Hervás Benito I; Mateo Navarro A Rev Esp Med Nucl; 1998; 17(3):158-61. PubMed ID: 9683854 [TBL] [Abstract][Full Text] [Related]
8. Iodine 131 uptake related to hair dyeing. Meyers A; Harry L; Peterson B Radiol Technol; 2007; 78(5):433-4. PubMed ID: 17519382 [No Abstract] [Full Text] [Related]
9. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning. Dam HQ; Kim SM; Lin HC; Intenzo CM Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323 [TBL] [Abstract][Full Text] [Related]
10. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan? Salvatori M; Perotti G; Rufini V; Maussier ML; Dottorini M Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184 [TBL] [Abstract][Full Text] [Related]
11. Nuclear imaging in the management of thyroid carcinoma. Cavalieri RR Thyroid; 1996 Oct; 6(5):485-92. PubMed ID: 8936676 [TBL] [Abstract][Full Text] [Related]
12. Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results? Ma C; Xie J; Kuang A J Nucl Med; 2005 Jul; 46(7):1164-70. PubMed ID: 16000286 [TBL] [Abstract][Full Text] [Related]
14. Artifactual I-131 activity in the hairs after thyroid remnant ablation. Bhargava P; Choi WS Thyroid; 2006 Nov; 16(11):1187-9. PubMed ID: 17123350 [No Abstract] [Full Text] [Related]
15. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer. Gerard SK; Dam HQ Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947 [No Abstract] [Full Text] [Related]
16. False-positive I-131 whole-body imaging after I-131 therapy for a follicular carcinoma. Andreas J; Brühl K; Eissner D Clin Nucl Med; 1997 Feb; 22(2):123-4. PubMed ID: 9031774 [No Abstract] [Full Text] [Related]
17. Unusual uptake of radioiodine in the chest in a patient with thyroid carcinoma. Nair N; Basu S; Pakhale H Br J Radiol; 2004 Jan; 77(913):63-7. PubMed ID: 14988142 [TBL] [Abstract][Full Text] [Related]
18. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I. Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552 [TBL] [Abstract][Full Text] [Related]
19. Normal gallbladder visualization during post-ablative iodine-131 scan of thyroid cancer. Seok JW; Kim SJ; Kim IJ; Kim YS; Kim YK J Korean Med Sci; 2005 Jun; 20(3):521-3. PubMed ID: 15953883 [TBL] [Abstract][Full Text] [Related]
20. Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma. Zerva B; Koutsikos J; Palestidis C; Kounadi E; Gerali S Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):348-54. PubMed ID: 17043633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]